Sumith A. Kularatne - Publications

Affiliations: 
On Target Laboratory 
Area:
Oncology, Drug design and development, Targeted-drugs for cancer and inflammatory diseases, immunotherapy, Image-guided surgery,

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Mahalingam SM, Kularatne SA, Myers CH, Gagare P, Norshi M, Liu X, Singhal S, Low PS. Evaluation of Novel Tumor-Targeted Near-Infrared Probe for Fluorescence-Guided Surgery of Cancer. Journal of Medicinal Chemistry. PMID 30296376 DOI: 10.1021/acs.jmedchem.8b01115  1
2018 Kularatne SA, Thomas M, Myers CH, Gagare P, Kanduluru AK, Crain CJ, Cichocki BN. Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery for Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30201762 DOI: 10.1158/1078-0432.CCR-18-0803  1
2018 Marks IS, Gardeen SS, Kurdziel SJ, Nicolaou ST, Woods JE, Kularatne SA, Low PS. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers. Molecular Pharmaceutics. PMID 29715036 DOI: 10.1021/acs.molpharmaceut.8b00139  0.96
2018 Predina JD, Newton AD, Xia L, Corbett C, Connolly C, Shin M, Sulyok LF, Litzky L, Deshpande C, Nie S, Kularatne SA, Low PS, Singhal S. An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas. Oncotarget. 9: 13517-13529. PMID 29568374 DOI: 10.18632/oncotarget.24399  0.96
2017 Predina JD, Newton AD, Connolly C, Dunbar A, Baldassari M, Deshpande C, Cantu E, Stadanlick J, Kularatne SA, Low PS, Singhal S. Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29241970 DOI: 10.1016/j.ymthe.2017.10.016  0.96
2017 Predina JD, Newton AD, Keating J, Barbosa EM, Okusanya O, Xia L, Dunbar A, Connolly C, Baldassari MP, Mizelle J, Delikatny EJ, Kucharczuk JC, Deshpande C, Kularatne SA, Low P, et al. Intraoperative Molecular Imaging Combined With Positron Emission Tomography Improves Surgical Management of Peripheral Malignant Pulmonary Nodules. Annals of Surgery. PMID 28746152 DOI: 10.1097/SLA.0000000000002382  0.88
2015 De Jesus E, Keating JJ, Kularatne SA, Jiang J, Judy R, Predina J, Nie S, Low P, Singhal S. Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging. International Journal of Molecular Imaging. 2015: 469047. PMID 26491562 DOI: 10.1155/2015/469047  0.88
2014 Kularatne SA, Deshmukh V, Ma J, Tardif V, Lim RK, Pugh HM, Sun Y, Manibusan A, Sellers AJ, Barnett RS, Srinagesh S, Forsyth JS, Hassenpflug W, Tian F, Javahishvili T, et al. A CXCR4-targeted site-specific antibody-drug conjugate. Angewandte Chemie (International Ed. in English). 53: 11863-7. PMID 25213874 DOI: 10.1002/anie.201408103  0.64
2013 Kularatne SA, Deshmukh V, Gymnopoulos M, Biroc SL, Xia J, Srinagesh S, Sun Y, Zou N, Shimazu M, Pinkstaff J, Ensari S, Knudsen N, Manibusan A, Axup JY, Kim CH, et al. Recruiting cytotoxic T cells to folate-receptor-positive cancer cells. Angewandte Chemie (International Ed. in English). 52: 12101-4. PMID 24573789 DOI: 10.1002/anie.201306866  0.96
2013 Henne WA, Kularatne SA, Hakenjos J, Carron JD, Henne KL. Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate. Bioorganic & Medicinal Chemistry Letters. 23: 5810-3. PMID 24064501 DOI: 10.1016/j.bmcl.2013.08.113  0.96
2013 Kularatne SA, Bélanger MJ, Meng X, Connolly BM, Vanko A, Suresch DL, Guenther I, Wang S, Low PS, McQuade P, Trotter DG. Comparative analysis of folate derived PET imaging agents with [(18)F]-2-fluoro-2-deoxy-d-glucose using a rodent inflammatory paw model. Molecular Pharmaceutics. 10: 3103-11. PMID 23819524 DOI: 10.1021/mp4001684  0.96
2013 Kelderhouse LE, Chelvam V, Wayua C, Mahalingam S, Poh S, Kularatne SA, Low PS. Development of tumor-targeted near infrared probes for fluorescence guided surgery. Bioconjugate Chemistry. 24: 1075-80. PMID 23642154 DOI: 10.1021/bc400131a  0.96
2013 Gent YY, Weijers K, Molthoff CF, Windhorst AD, Huisman MC, Smith DE, Kularatne SA, Jansen G, Low PS, Lammertsma AA, van der Laken CJ. Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis. Arthritis Research & Therapy. 15: R37. PMID 23452511 DOI: 10.1186/ar4191  0.96
2012 Vaitilingam B, Chelvam V, Kularatne SA, Poh S, Ayala-Lopez W, Low PS. A folate receptor-α-specific ligand that targets cancer tissue and not sites of inflammation. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1127-34. PMID 22693311 DOI: 10.2967/jnumed.111.099390  0.96
2012 Dubrovska A, Elliott J, Salamone RJ, Telegeev GD, Stakhovsky AE, Schepotin IB, Yan F, Wang Y, Bouchez LC, Kularatne SA, Watson J, Trussell C, Reddy VA, Cho CY, Schultz PG. CXCR4 expression in prostate cancer progenitor cells. Plos One. 7: e31226. PMID 22359577 DOI: 10.1371/journal.pone.0031226  0.96
2012 Yang JJ, Kularatne SA, Chen X, Low PS, Wang E. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys. Molecular Pharmaceutics. 9: 310-7. PMID 22171616 DOI: 10.1021/mp200483t  0.96
2012 Henne WA, Kularatne SA, Ayala-López W, Doorneweerd DD, Stinnette TW, Lu Y, Low PS. Synthesis and activity of folate conjugated didemnin B for potential treatment of inflammatory diseases. Bioorganic & Medicinal Chemistry Letters. 22: 709-12. PMID 22100311 DOI: 10.1016/j.bmcl.2011.10.042  0.96
2010 Kularatne SA, Venkatesh C, Santhapuram HK, Wang K, Vaitilingam B, Henne WA, Low PS. Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs. Journal of Medicinal Chemistry. 53: 7767-77. PMID 20936874 DOI: 10.1021/jm100729b  0.96
2010 Kularatne SA, Low PS. Targeting of nanoparticles: folate receptor. Methods in Molecular Biology (Clifton, N.J.). 624: 249-65. PMID 20217601 DOI: 10.1007/978-1-60761-609-2_17  0.96
2009 Thomas M, Kularatne SA, Qi L, Kleindl P, Leamon CP, Hansen MJ, Low PS. Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues. Annals of the New York Academy of Sciences. 1175: 32-9. PMID 19796075 DOI: 10.1111/j.1749-6632.2009.04977.x  0.96
2009 Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. Current Opinion in Chemical Biology. 13: 256-62. PMID 19419901 DOI: 10.1016/j.cbpa.2009.03.022  0.96
2009 Yi YS, Ayala-López W, Kularatne SA, Low PS. Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies. Molecular Pharmaceutics. 6: 1228-36. PMID 19374407 DOI: 10.1021/mp900070b  0.96
2009 Kularatne SA, Wang K, Santhapuram HK, Low PS. Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. Molecular Pharmaceutics. 6: 780-9. PMID 19361233 DOI: 10.1021/mp900069d  0.96
2009 Kularatne SA, Zhou Z, Yang J, Post CB, Low PS. Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted (99m)Tc-radioimaging agents. Molecular Pharmaceutics. 6: 790-800. PMID 19361232 DOI: 10.1021/mp9000712  0.96
2008 He W, Kularatne SA, Kalli KR, Prendergast FG, Amato RJ, Klee GG, Hartmann LC, Low PS. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. International Journal of Cancer. Journal International Du Cancer. 123: 1968-73. PMID 18661519 DOI: 10.1002/ijc.23717  0.96
2006 Henne WA, Doorneweerd DD, Hilgenbrink AR, Kularatne SA, Low PS. Synthesis and activity of a folate peptide camptothecin prodrug. Bioorganic & Medicinal Chemistry Letters. 16: 5350-5. PMID 16901694 DOI: 10.1016/j.bmcl.2006.07.076  0.96
Show low-probability matches.